Cancer

The McGill University Health Centre’s Dr. Renzo Cecere wins the 2024 Trottier Webster Innovation Award

The McGill University Health Centre’s Dr. Renzo Cecere wins the 2024 Trottier Webster Innovation Award Marie-Hélène Laramée, Dr Renzo Cecere,…

1 year ago

HUTCHMED Announces Continued Inclusion of ORPATHYS® (savolitinib) in the National Reimbursement Drug List in China at Current Terms

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Nov. 28, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM; HKEX:​13)…

1 year ago

Rakovina Therapeutics Announces Private Placement Offering

The Company has received initial commitments totaling over $800,000 from strategic investors in connection with the OfferingVANCOUVER, British Columbia, Nov.…

1 year ago

Celularity Inc. Announces Receipt of Nasdaq Notification

FLORHAM PARK, N.J., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a regenerative medicine company developing…

1 year ago

Theralase(R) Release’s 3Q2024 Financial Statements

TORONTO, ON / ACCESSWIRE / November 27, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ")…

1 year ago

Lunit Inks Partnership with Salud Digna to Advance AI in Medical Imaging

AI-powered chest X-ray and mammography analysis solutions to be deployed across one of Mexico's largest healthcare networksSEOUL, South Korea, Nov.…

1 year ago

Self Regional Healthcare Brings Future-Ready Enterprise Imaging Cloud Technology Into South Carolina With AGFA Healthcare

Self Regional Healthcare aims to upgrade its PACS, enhance diagnostic imaging capabilities, and strengthen its financial position while optimizing staff…

1 year ago

SELLAS Announces Positive Data from Preclinical Studies Indicating ASXL1 Mutations as Predictor of Response to SLS009 in Solid Cancers

- Preselection Method for Cancers Responding to SLS009: High Efficacy of SLS009 Observed in 67% of ASXL1 Mutated Solid Cancers…

1 year ago

Prenetics Announces Third Quarter 2024 Financial Results

Revenue Grew 59.4% to $7.8 million from Prior Year and 30.9% Sequentially Officially Launched IM8Health.com, a new premium supplements brand…

1 year ago

CytomX Therapeutics to Present at the 36th Annual Piper Sandler Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Nov. 27, 2024 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field…

1 year ago